Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Montréal

$72,000.00

Reaction Mechanisms and Methodology for the Design and Synthesis of Bioactive Agents.

EF 2024-25

Résumé
The main objective of our research program is to develop novel methodologies and strategies to access challenging molecular scaffolds. Our research program will benefit Canadians through the advancement of our collective knowledge in chemistry and should also bring positive socio-economical impacts and health benefits. Some of our novel nucleoside analogues demonstrate remarkable activity against pancreatic cancer cell lines that do not respond to the clinical gold standard of treatment (Gemcitabine). Another family of molecules of this class protects the heart against cardiotoxic agents, such as anticancer drugs, and is remarkably active in heart failure models. These advancements were born out of our long-standing interest in free-radical based chemistry combined with our commitment to develop alternative methods to prepare nucleoside analogues. The highly reactive nature of radical intermediates was harnessed to produce stereogenic all-carbon quaternary centers that can be introduced at C3' or C2' of nucleoside scaffolds. Our key strategy for the synthesis of nucleoside analogues involves diastereoselective formation of acyclic thioaminals by introducing a nucleobase on dithioacetals, followed by kinetically controlled cyclizations. We plan to further improve the synthesis of our lead molecules and prepare photoaffinity probes to elucidate their mechanism of action in collaboration with research groups with expertise in cancer and cardioprotection. The free-radical approaches will also be applied to synthesize biologically relevant terpenes and analogues thereof, such as dictyoceratins A and C, a potential new avenue to antiproliferative agents. Finally, we are actively working on the discovery of E- and P- selectin antagonists that are key mediators in the immune system's inflammatory response. The objective of our synthetic design is to restrict the relevant pharmacophores of the endogenous polysaccharide, sialyl LewisX (sLeX), to mimic analogues that are locked in the bioactive conformation. This project stimulated us to elaborate efficient strategies to prepare bicyclic-like analogues of natural sugars that could find various biological applications.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2020-06507
Name nom
Guindon, Yvan
Department département
Chimie - Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Reaction Mechanisms and Methodology for the Design and Synthesis of Bioactive Agents.
Keywords
organic synthesis; synthetic methodology; stereoselective transformations; free-radical intermediates; photoredox catalysis; all-carbon quaternary center; nucleoside analogues; glycomimetics; cancer; cardioprotection
Application summary
The main objective of our research program is to develop novel methodologies and strategies to access challenging molecular scaffolds. Our research program will benefit Canadians through the advancement of our collective knowledge in chemistry and should also bring positive socio-economical impacts and health benefits. Some of our novel nucleoside analogues demonstrate remarkable activity against pancreatic cancer cell lines that do not respond to the clinical gold standard of treatment (Gemcitabine). Another family of molecules of this class protects the heart against cardiotoxic agents, such as anticancer drugs, and is remarkably active in heart failure models. These advancements were born out of our long-standing interest in free-radical based chemistry combined with our commitment to develop alternative methods to prepare nucleoside analogues. The highly reactive nature of radical intermediates was harnessed to produce stereogenic all-carbon quaternary centers that can be introduced at C3' or C2' of nucleoside scaffolds. Our key strategy for the synthesis of nucleoside analogues involves diastereoselective formation of acyclic thioaminals by introducing a nucleobase on dithioacetals, followed by kinetically controlled cyclizations. We plan to further improve the synthesis of our lead molecules and prepare photoaffinity probes to elucidate their mechanism of action in collaboration with research groups with expertise in cancer and cardioprotection. The free-radical approaches will also be applied to synthesize biologically relevant terpenes and analogues thereof, such as dictyoceratins A and C, a potential new avenue to antiproliferative agents. Finally, we are actively working on the discovery of E- and P- selectin antagonists that are key mediators in the immune system's inflammatory response. The objective of our synthetic design is to restrict the relevant pharmacophores of the endogenous polysaccharide, sialyl LewisX (sLeX), to mimic analogues that are locked in the bioactive conformation. This project stimulated us to elaborate efficient strategies to prepare bicyclic-like analogues of natural sugars that could find various biological applications.